Publicações

Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study

AuthID
P-00Z-QRF

Author(s)

Rossari, F

Tada, T

Shimose, S

Kudo, M

Yoo, C

Cheon, J

Finkelmeier, F

Lim, HY

Presa, J

Masi, G

Bergamo, F

Amadeo, E

Vitiello, F

Foti, S

Persano, M

Piscaglia, F

Scartozzi, M

Cascinu, S

Rimini, M

Gardini, AC

Document Type

Abstract

Year published

2023

Published

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 34, Pages: S1547-S1547 (1)

Conference

Annual Meeting of the European-Society-For-Medical-Oncology (Esmo), Date: DEC 01-03, 2023, Location: SINGAPORE

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.annonc.2023.10.764

Wos: WOS:001122475400188

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study

Useful Links

Get Help

Autenticação Federada (Click on the image)

Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study

Useful Links

Get Help